PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2123183-10	1990	This study shows that addition of glibenclamide to insulin treatment is advantageous in NIDDM patients showing secondary failure to OHA.	10-oxohexadecanoic acid	132-135	insulin	Homo sapiens	51-58